Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

1150 - Transcriptomic analysis of bronchoalveolar lavage cells from advanced non-small cell lung cancer identifies overexpressed immunoglobulin genes of immunosuppressive implication


09 Sep 2017


Poster display session


Cancers in Adolescents and Young Adults (AYA);  Translational Research;  Non-Small Cell Lung Cancer


Chih-Hsi Kuo


Annals of Oncology (2017) 28 (suppl_5): v460-v496. 10.1093/annonc/mdx380


C.S. Kuo1, C. Liu1, Y. Lo2, Y. Wang1, T. Wang3, C. Yang1

Author affiliations

  • 1 Thoracic Medicine, Chang Gung Memorial Hospital-Taipei, 105 - Taipei/TW
  • 2 Airway Disease, Chang Gung Memorial Hospital-Taipei, 105 - Taipei/TW
  • 3 Genomic Medicine Research Core Laboratory, Chang Gung Memorial Hospital-Taipei, 105 - Taipei/TW


Abstract 1150


Diverse pattern of inflammatory cells infiltration in the microenvironment of non-small cell lung cancers (NSCLCs) has key implication for successful immunotherapeutic approaches (Gajewski et al. Nat Immunol 2013). However, study of these cells remains challenging particularly in advanced disease where tumor resection is never possible. We hypothesized that transcriptomic study of bronchoalveolar lavage (BAL) cells is useful in this setting to identify characteristic gene expression of immunological significance.


BAL cells were obtained from 13 patients of advanced NSCLC and 6 normal controls. In NSCLC group, lavage was performed from the lung segment where tumor was located. RNA was extracted and hybridized to Affymetrix HG-U133 plus2 transcriptomic microarray. Raw intensity data was normalized by Robust Multi-Array Average and analyzed for differential expressed genes (DEGs) using Bioconductor R limma package.


A total 129 DEGs were identified whose gene ontology enrichment analysis revealed the top over-represented pathways as circulating immune complex (GO: 0042571, p=2.2x10−10), FCGR activation (REAC: 2029481, p=5.4x10−11), and regulation of B cell activation (GO: 0050864, p=2.4x10−5), in which a number of up-regulated genes encoding immunoglobulins, Src family kinases and interleukin (IL)-10 were noted. We integrated the immunoglobulin genes into a signature and calculated the enrichment score for each subject using Gene Set Variation Analysis (Sonja et al. BMC Bioinformatics 2013). Medium to high correlation of immunoglobulin signature with IL-10 (Pearson’s r: 0.64, p=0.003), with FCGR2B (Pearson’s r: 0.43, p=0.066) and FCGR2B with IL-10 (Pearson’s r: 0.50, p=0.029) were determined. In addition, mild to medium correlation were identified between IL-10 and Src family kinases BLK (Pearson’s r: 0.48, p=0.038), LCK (Pearson’s r: 0.40, p=0.090) and YES1 (Pearson’s r: 0.25, p=0.300).


Transcriptome of BAL cells around advanced NSCLCs showed characteristic expression of immunoglobulin signature that may implicate the immunosuppressive property in tumor milieu.

Clinical trial identification

Legal entity responsible for the study

Chih-Hsi Scott Kuo MD


Chang Gung Medical Foundation


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.